In recognition of the new, highly effective therapies for hepatitis C which were approved for use by the Scottish Medicines Consortium in 2014, the Scottish Government has provided additional recurring funding to NHS boards from 2015-16 to assist with the costs of new drugs, including hepatitis C therapies.